© 2020 MJH Life Sciences and Cure Today. All rights reserved.
© 2020 MJH Life Sciences™ and Cure Today. All rights reserved.
November 16, 2019
Cancer can trigger symptoms that seem as mysterious as their name: paraneoplastic syndromes.
November 19, 2019
Three survivors describe what life looks like seven and 15 years out from diagnosis.
Patients with RET-fusion-positive non-small cell lung cancer (NSCLC) had a high response to LOXO-292 (selpercatinib), according to findings from the largest clinical trial of patients with RET-altered cancers.
November 20, 2019
An aptly named app brings community to patients and caregivers around the world.
Results uncover a need to ensure understanding and give adequate information about genomics in risk of other disease, familial cancer.
November 26, 2019
How one mother learned that “broken hearts still beat.”
November 22, 2019
Disparities in lung cancer care must be closed to improve patient outcomes.
November 23, 2019
How a cancer diagnosis leaves one woman feeling humbled.
November 24, 2019
From the Chairman
New therapies approved following innovative research are increasing survival rates for patients with advanced lung cancer.
Paraneoplastic syndromes are uncommon disorders that can arise with any cancer type but are more common with lung cancer.
New therapies offer options for patients with non-small cell lung cancer whose disease has spread to the brain.